AAM Urges Congress To Re-evaluate Blocking Act

Report Claims Legislation Could Cost $1.7bn For Each Generic Delayed

 
• By Akriti Seth
  
Dollars
The Blocking Act may “cause delays in generic entry and significant missed savings opportunities” • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin